Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men-Reference-Cited by-同舟云学术

Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men

Published:2014-03-06 Issue:6 Volume:31 Page:728-732
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Asferg C. L.¹,Andersen U. B.¹,Linneberg A.²³,Goetze J. P.³⁴,Jeppesen J. L.³⁵

Affiliation:

1. Department of Diagnostics

2. Research Centre for Prevention and Health; Copenhagen University Hospital Glostrup; Glostrup

3. Faculty of Health Sciences; University of Copenhagen

4. Department of Clinical Biochemistry; Rigshospitalet, Copenhagen University Hospital; Copenhagen

5. Department of Medicine; Copenhagen University Hospital Glostrup; Glostrup Denmark

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.12411/fullpdf

Reference18 articles.

1. Diabetes and hypertension and atherosclerotic cardiovascular disease - related or separate entities often found together;Torp-Pedersen;Hypertension,2011

2. Physiology of vasopressin relevant to management of septic shock;Holmes;Chest,2001

3. Bench-to-bedside review: vasopressin in the management of septic shock;Russell;Crit Care,2011

4. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure;Alehagen;J Am Med Assoc,2011

5. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome;Saleem;J Clin Endocrinol Metab,2009

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus;International Journal of Molecular Sciences;2024-01-21

2. Copeptin as a novel biomarker of cardiometabolic syndrome;Endokrynologia Polska;2021-10-29

3. Copeptin, a surrogate marker of arginine8 vasopressin, has no ability to modulate human and mouse gastric motility;European Journal of Pharmacology;2021-02

4. Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?;Journal of Pediatric Endocrinology and Metabolism;2020-11-19

5. The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome;Endocrine Connections;2020-07